KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$6.0 million.

  • Biolife Solutions' Cash from Investing Activities fell 25496.73% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $961000.0, marking a year-over-year increase of 10844.46%. This contributed to the annual value of $58.3 million for FY2024, which is 22684.87% up from last year.
  • Biolife Solutions' Cash from Investing Activities amounted to -$6.0 million in Q3 2025, which was down 25496.73% from -$39.5 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Cash from Investing Activities peaked at $73.6 million during Q4 2024, and registered a low of -$39.5 million during Q2 2025.
  • For the 5-year period, Biolife Solutions' Cash from Investing Activities averaged around -$3.6 million, with its median value being -$2.5 million (2021).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 176093.0% in 2024, then plummeted by 1219683.26% in 2025.
  • Biolife Solutions' Cash from Investing Activities (Quarter) stood at -$2.5 million in 2021, then plummeted by 485.92% to -$14.9 million in 2022, then soared by 126.57% to $4.0 million in 2023, then surged by 1760.93% to $73.6 million in 2024, then crashed by 108.1% to -$6.0 million in 2025.
  • Its Cash from Investing Activities stands at -$6.0 million for Q3 2025, versus -$39.5 million for Q2 2025 and -$27.2 million for Q1 2025.